COVID pills in Indiana: Current supplies of Pfizer, Merck an

Indiana has received nearly 7,000 courses of new medications designed to treat COVID-19, state leaders announced Wednesday.

Related Keywords

Indiana , United States , Merck Molnupiravir , Astrazeneca Evusheld , Veklury Remdesivir , Eli Lilly Bamlanivimab , Glaxosmithkline Sotrovimab , Indiana State Department Of Health , Heath Department , Pfizer , Walgreens , Us Department Of Health , Human Services , Lindsay Weaver , Indiana State Department , Eric Holcomb , Smithkline Sotrovimab , Lilly Bamlanivimab ,